Los Angeles, CA 11/9/09—LC column developer and supplier Phenomenex has filed suit against Thermo Fisher Scientific in the US District Court for the Central District of California, alleging false advertising and unfair competition. The action is in connection with an email sent in October by a Thermo Fisher product manager to US distributors. Phenomenex seeks […]
Boston, MA 12/2/09; Boston, MA 12/29/09—Thermo Fisher Scientific has filed suit against Innov-X Systems, a developer and manufacturer of X-ray Fluorescence (XRF) systems. The suit filed in US District Court for the District of Massachusetts charges Innov-X with false advertising, unfair competition, deceptive trade practices, intentional interference with business relations, product disparagement and business defamation. […]
Brussels, Belgium 12/22/09—Dow Jones has reported that the European Commission (EC) extended the deadline for its antitrust review of Agilent’s acquisition of Varian (see IBO 7/31/09) by 10 working days to January 20. By that date, the EC will either clear the acquisition or launch an investigation. The extension was due to “commitments” by Agilent […]
Washington, DC 12/18/09; London, England 12/18/09—Diversified technology firm Danaher has announced a £50 million ($82 million) offer, net of cash acquired, for publicly held Genetix, a maker of research and clinical diagnostic instruments. In 2009, Genetix generated revenues of £26 million ($42 million) (see IBO 3/15/09). Danaher proposes to acquire all the issued and to […]
This month, President Obama signed the US Department of Health and Human Services’ (HHS) appropriations bill for fiscal 2010, starting October 1, 2009 (see IBO 12/15/09). The HHS budget increased 5.3% to $803.5 billion The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), both part of the HHS, benefited […]
In 2009, the world economic downturn exposed a fragile and unregulated global financial system. Virtually every economy was impacted by the collapse of the financial system, as the Morgan Stanley Capital International (MSCI) All-Country World Index fell 24.1% during the first quarter of 2009. However, a concerted effort by international governments to support the credit […]
Although its application to pharmaceutical manufacturing is a relatively recent development, one of the earliest applications for Simulated Moving Bed (SMB) chromatography was in the petrochemical industry. The use of SMB chromatography in the petrochemical industry goes back several decades. The technique, which offers a method for continuous chromatography, is useful for large-scale separation of […]
Company Announcements In August, plaintiffs dismissed their class action suit against VWR alleging the sale of chemicals to Saddam Hussein’s regime that were later used as weapons (see IBO 7/31/09). In October, the same action against Thermo Fisher Scientific was dismissed. Bruker Energy & Supercon Technologies announced the election of three new directors to expand […]
Company Announcements Life Technologies appointed Jay Therrien as vice president, Global Sales for Next Generation Sequencing. Most recently, he served as director of Sales for Asia Pacific and Japan at Illumina. Fluidigm appointed Nano Gen Teknolojileri as its exclusive distributor for the BioMark and EP1 Systems in Turkey. GE formed the “GE Healthyimagination Fund,” an […]
Company Announcements Cellix named Crisel Instruments as an Italian distributor and Chromaphor Analysen-Tecknik as a German distributor. GE Healthcare named Stephen Minger, PhD, as head of R&D for Cell Technologies in September. He was previously senior lecturer and director of King’s College London’s Stem Cell Biology Laboratory. In October, Enzo Biochem Life Sciences announced a […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
